Andy Crosbie is the Manager of Post-market Surveillance Strategy in MHRA’s Devices Division. He has over 30 years of experience working on the safety and regulation of implantable medical devices (particularly joint replacements and breast implants) and he played a key role in the establishment of the UK National Joint Registry. He has also represented Europe on the International Medical Device Regulatory Forum (IMDRF) working group on device registries. Andy leads MHRA work on UDI and he is a member of the European UDI working group and the GS1 UK Healthcare User Group.
Medicines & Healthcare Products Regulatory Agency Manager of Post-market Surveillance Strategy, Manager of Post-market Surveillance Strategy
Panel – Implant Registries – impacts for manufactures, hospitals, governments and patients